Abstract:
A method of isolating or counting target cells using photocleavable linkers coupled with fluorescent dyes, for qualitative or quantitative analysis of protein, gene analysis, and/or morphological analysis after removing the dye.
Abstract:
Disclosed is a server apparatus. The server apparatus comprises: a communication unit for communicating with a user terminal apparatus; a storage for storing compatible information between devices; and a processor for, if the user terminal apparatus accesses the server apparatus and identification information on the user terminal apparatus is received from the user terminal apparatus, generating recommended device information compatible with the user terminal apparatus on the basis of the information stored in the storage and transmitting the recommended device information to the user terminal apparatus.
Abstract:
An anti c-Met antibody or antigen-binding fragment thereof comprising a heavy-chain variable region having heavy-chain complementarity determining region (CDR) amino acid sequences of SEQ ID NOs: 1, 2 and 3, and a light-chain variable region having light-chain CDR amino acid sequences of SEQ ID NOs: 4, 5, and 6; and a method of wound healing, tissue regeneration, or cell proliferation comprising administration of same; as well as related compositions and methods.
Abstract translation:包含具有SEQ ID NO:1,2和3的重链互补决定区(CDR)氨基酸序列的重链可变区的抗c-Met抗体或其抗原结合片段和轻链可变区 具有SEQ ID NO:4,5和8的轻链CDR氨基酸序列; 以及伤口愈合,组织再生或细胞增殖的方法,包括施用它们; 以及相关的组合物和方法。
Abstract:
A user terminal device is provided. The user terminal device includes: a touch display configured to display a screen; and a controller configured to execute a function of an application corresponding to a touch gesture having a predetermined pattern using a content included in a selected region when the touch gesture is received in a state in which a partial region on the screen is selected.
Abstract:
A deimmunized anti c-Met humanized antibody and a pharmaceutical composition including the same, and method for the prevention and treatment of cancer.
Abstract:
An antibody or antigen binding fragment thereof that specifically binds to an epitope in a SEMA domain of c-Met protein, and pharmaceutical compositions, methods, kits, nucleic acids, and cells related thereto.